Summary
IDEXX Laboratories, Inc. (IDXX) announced a change in its Board of Directors composition. Ms. M. Anne Szostak has notified the company of her intention to retire from the Board, effective immediately after the 2026 Annual Meeting of Stockholders on May 12, 2026. Her retirement is not due to any disagreements concerning the company's operations or policies, indicating a smooth transition. The company expressed gratitude for her significant contributions and leadership since 2012. The Board will reduce the size of the Class III directors upon Ms. Szostak's retirement. This reduction, however, will be offset by the previously announced appointment of Michael G. Erickson, PhD, as a Class II director, also effective immediately following the 2026 Annual Meeting. Investors should note that these changes are procedural and do not appear to reflect any underlying issues with the company's performance or governance.
Key Highlights
- 1Ms. M. Anne Szostak to retire from the Board of Directors effective May 12, 2026.
- 2Retirement is effective immediately following the 2026 Annual Meeting of Stockholders.
- 3Ms. Szostak's retirement is voluntary and not due to any disagreements with the Company or Board.
- 4The Board will reduce the size of the Class III directors upon Ms. Szostak's retirement.
- 5The overall size of the Board will not decrease due to the concurrent appointment of Michael G. Erickson, PhD.
- 6Michael G. Erickson, PhD, will join the Board as a Class II director following the 2026 Annual Meeting.
- 7The company expresses gratitude for Ms. Szostak's service since 2012.